AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System is designed to help overcome the challenges of aorto-ostial stenting and compliments the Mynx® Product Family of Vascular Closure Devices to expand AccessClosure’s portfolio.

Data from a study led by researchers at Saint Luke's Mid America Heart Institute<http://globalmessaging1.prnewswire.com/clickthrough/servlet/clickthrough?msg_id=7563978&adr_order=59&url=aHR0cDovL3d3dy5zYWludGx1a2VzaGVhbHRoc3lzdGVtLm9yZy9zZXJ2aWNlcy9oZWFydC1hbmQt%0AdmFzY3VsYXItY2FyZGlvdmFzY3VsYXItc2VydmljZXM%3D> showed marked, long-term improvement in health status in patients suffering from peripheral artery disease treated with the S.M.A.R.T. Nitinol Self-Expandable Stent. The study was sponsored by Cordis Corporation, (Fremont, Calif.), manufacturer of the S.M.A.R.T. Stent.

BIOTRONIK, a leading manufacturer of cardiovascular technology, announced today that it has completed patient enrollment in the iliac arm of its BIOFLEX-I trial. Under the supervision of national primary investigator Dr. Mark W. Burket, Chief of the Cardiovascular Division at the University of Toledo Medical Center in Toledo OH, the trial will evaluate the safety and effectiveness of the Astron and Pulsar-18 stents in the treatment of peripheral vascular disease with a view towards gaining FDA approval.

Dr. Michael Pfeiffer, a cardiologist and assistant professor of medicine at Penn State Hershey Heart and Vascular Institute in Hershey, Pa. discusses the advantages of 3D volume echocardiography in the right heart.

On Thursday evening, the Montreal Heart Institute (MHI) inaugurated its brand new Philippa and Marvin Carsley Cardiovascular Magnetic Resonance Centre, in honour of the loyal donors. Their generous contribution will allow the MHI to operate this equipment, positioning our hospital as one of the leading cardiology centres specialized in cardiovascular imaging.

The directors of CVPath Institute, a leading cardiovascular research organization, have appointed Dr. Michael Joner as the Institute&#39;s new Chief Executive Officer, announced Dr. Renu Virmani, CVPath&#39;s founder, president and medical director. His appointment became effective August 15, 2013. &nbsp;

Christopher Adams, M.D., a cardiology fellow with the department of cardiology, Joan C. Edwards School of Medicine, recently received the James Willerson Clinical Award Competition for Residents and Fellows from the International Academy of Cardiovascular Sciences (IACS). &nbsp;The award was established to promote, encourage and recognize young talents in cardiovascular science, medicine and surgery.

Christopher Adams, M.D., a cardiology fellow with the department of cardiology, Joan C. Edwards School of Medicine, recently received the James Willerson Clinical Award Competition for Residents and Fellows from the International Academy of Cardiovascular Sciences (IACS). &nbsp;The award was established to promote, encourage and recognize young talents in cardiovascular science, medicine and surgery.&nbsp;